Achromatopsia is a condition characterized by a partial or total absence of color vision. People with complete achromatopsia cannot perceive any colors; they see only black, white, and shades of gray. Incomplete achromatopsia is a milder form of the condition that allows some color discrimination.
DelveInsight’s “Achromatopsia Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Achromatopsia, historical and forecasted epidemiology as well as the Achromatopsia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some key facts of Achromatopsia Market are:
Achromatopsia is a rare disorder with an estimated prevalence of fewer than 1:30,000
The congenital forms of the Achromatopsia are considered stationary and do not worsen with age.
Visual acuity and stability of the eye motions generally improve during the first six to seven years of life – but remain near 20/200.
Scope of the Achromatopsia Report
The report covers the descriptive overview of Achromatopsia, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
Comprehensive insight has been provided into the Achromatopsia epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Achromatopsia are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of Achromatopsia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Achromatopsia market
Request for Sample Report: https://www.delveinsight.com/sample-request/achromatopsia-market
Achromatopsia also involves other problems with vision, including an increased sensitivity to light and glare (photophobia), involuntary back-and-forth eye movements (nystagmus), and significantly reduced sharpness of vision (low visual acuity). Affected individuals can also have farsightedness (hyperopia) or, less commonly, nearsightedness (myopia). These vision problems develop in the first few months of life.
Achromatopsia Companies covered:
EMAS Pharma
Janssen Research & Development
Applied Genetic Technologies Corp
MeiraGTx UK II Ltd
Syne Qua Non Limited
And Many Others
AAV – CNGB3
AAV – CNGA3
AGTC-402
rAAV2tYF-PR1.7-hCNGB3
And Many Others
Request for Sample Report: https://www.delveinsight.com/sample-request/achromatopsia-market
Table of Contents:
1. Key Insights
2. Executive Summary of Achromatopsia
3. Competitive Intelligence Analysis for Achromatopsia
4. Achromatopsia: Market Overview at a Glance
4.1. Achromatopsia Total Market Share (%) Distribution in 2017
4.2. Achromatopsia Total Market Share (%) Distribution in 2030
5. Achromatopsia: Disease Background and Overview
6. Patient Journey
7. Achromatopsia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Achromatopsia Treatment and Management
8.2. Achromatopsia Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Achromatopsia Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Achromatopsia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Achromatopsia
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/achromatopsia-market
